Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Catheter Precision, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
12.06. | Catheter Precision, Inc. Comments on Recent Market Activity | 77 | GlobeNewswire (Europe) | FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing... ► Artikel lesen | |
12.06. | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Key Progress for the LockeT Product | 4 | GlobeNewswire (USA) | ||
09.06. | Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | 1 | GlobeNewswire (USA) | ||
CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
09.06. | Catheter Precision gibt Aktienoptionsschein an Ladenburg Thalmann aus | 2 | Investing.com Deutsch | ||
06.06. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
30.05. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
27.05. | Catheter Precision Inc.: Catheter Precision, Inc. Receives CE Mark for LockeT | 1 | GlobeNewswire (USA) | ||
19.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.05. | Catheter Precision reports Q1 results | 3 | Seeking Alpha | ||
14.05. | Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | 1.095 | GlobeNewswire (Europe) | FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
13.05. | Catheter Precision raises $1.5M via private placement | 2 | Seeking Alpha | ||
13.05. | Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | 5 | GlobeNewswire (USA) | ||
08.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.04. | Catheter Precision to acquire late-stage heart failure treatment assets in development | 1 | Seeking Alpha | ||
17.04. | Catheter Precision, Inc.: Catheter Precision Makes NYSE American Section 610(b) Public Announcement | 1 | GlobeNewswire (USA) | ||
16.04. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
01.04. | Catheter Precision, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
28.03. | Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results | 296 | GlobeNewswire (Europe) | FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
12.03. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 42,570 | +0,90 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 48,170 | +0,25 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
ECKERT & ZIEGLER | 67,10 | +0,90 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
BICO GROUP | 3,272 | +1,05 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
CARDINAL HEALTH | 141,50 | 0,00 % | Cardinal Health stock hits all-time high at 166.3 USD | ||
RESMED | 221,00 | +0,91 % | ResMed-Aktie: Kurs steigt nur geringfügig (220,1782 €) | An der US-amerikanischen Börse ist die Aktie von ResMed zur Stunde unauffällig. Der jüngste Kurs betrug 254,22 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich aktuell... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,704 | -5,38 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
UNIDOC HEALTH | 0,135 | -2,17 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
ZIMMER BIOMET | 78,10 | -1,11 % | Dividendenbekanntmachungen (26.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AUDIUS SE DE000A40ET13 - 0,2 EUR B&M EUROPEAN VALUE RETAIL SA LU1072616219 0,097 GBP 0,1136 EUR BUILD-A-BEAR WORKSHOP INC US1200761047 0... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
CO-DIAGNOSTICS | 0,208 | -3,70 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
VERU | 0,554 | -0,90 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
CYTOSORBENTS | 0,981 | -1,70 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen |